ECSP993224A - N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina - Google Patents

N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina

Info

Publication number
ECSP993224A
ECSP993224A ECSP993224A ECSP993224A EC SP993224 A ECSP993224 A EC SP993224A EC SP993224 A ECSP993224 A EC SP993224A EC SP993224 A ECSP993224 A EC SP993224A
Authority
EC
Ecuador
Prior art keywords
quinazolin
acrylamide
propoxi
morfolin
phenylamine
Prior art date
Application number
Other languages
English (en)
Inventor
Alexander J Bridges
Denise Driscoll
Wayne Daniel Klohs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993224 priority Critical patent/ECSP993224A/es
Publication of ECSP993224A publication Critical patent/ECSP993224A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona el compuesto N-[4-(3-cloro-4-fluoro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il] acrilamida que es un inhibidor irreversible de las cinasas de la lirosina. También se proporciona un método para tratar el cáncer, restenosis, aterosclerosis, endometriosis, y psoriasis usando el compuesto N-[4-(3-cloro-4fluoro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]acrilamida, y una composición farmacéutica que contiene el compuesto N-[4-(3-cloro-4-fluoro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]acrilamida.
ECSP993224 1999-11-18 1999-11-18 N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina ECSP993224A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993224 ECSP993224A (es) 1999-11-18 1999-11-18 N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993224 ECSP993224A (es) 1999-11-18 1999-11-18 N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina

Publications (1)

Publication Number Publication Date
ECSP993224A true ECSP993224A (es) 2000-01-27

Family

ID=42044212

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993224 ECSP993224A (es) 1999-11-18 1999-11-18 N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina

Country Status (1)

Country Link
EC (1) ECSP993224A (es)

Similar Documents

Publication Publication Date Title
UY25809A1 (es) N-[4-(3-cloro-4-fluoro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina
ES2174250T3 (es) Inhibidores irreversibles de las quinasas de tirosina.
TW200420544A (en) Preparation of substituted quinazolines
CY1105618T1 (el) Δικυκλικες ετεροαρωματικες ενωσεις ως αναστολεις της κινασης τυροσινης πρωτεϊνης
DE60221886D1 (de) 3-cyanochinoline als inhibitoren von egf-r- und her2-kinasen
NO20002166D0 (no) Anvendelse av quinazolinderivater som tyrosinkinaseinhibitorer for behandling av kolonpolypper
DE60232994D1 (de) Inhibitoren von mitotischem kinesin
AU2002361846A1 (en) Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
BR9810366A (pt) Derivados de ácido 4-bromo ou 4-iodo fenilamino benzidroxîmico e seu uso como inibidores de mek
ATE234810T1 (de) Anthranilsäurederivate als inhibitoren der c-gmp- phosphodiesterase
UY25714A1 (es) Método para tratar ateroesclerosis empleando un inhibidor de ap2 y combinación.
AU2002364211A1 (en) Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
DE69936150D1 (de) Indomethacin-amidderivate zur antiangiogenen und/oder antitumorigen verwendung
PE20040990A1 (es) Combinaciones de inhibidores de quinasa de erb b y farmacos antineoplasicos
ECSP993224A (es) N-[-4-(3-cloro-4-fluoro- fenilamino)-7 - (3 -morfolin-4- il -propoxi) - quinazolin- 6-il]-acrilamida, un inhibidor irreversible de las cinasas de la tirosina
GT199800081A (es) Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para el tratamiento delcancer.
ITMI20021012A1 (it) Combinazione di un inibitore dell'enzima hmg-coa reduttasi e di un estere nitrato
BR0209776A (pt) Composições de inibidores seletivos de ciclo oxigenase-2 e radiação para inibição ou prevenção de doença cardiovascular
EA200300094A1 (ru) Полиморфные формы/гидраты дигидрохлорида n-[4-(3-хлор-4-фторфениламино)-7-(3-морфолин-4-илпропокси)хиназолин-6-ил]-акриламида
ATE283852T1 (de) Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen
ECSP951390A (es) Derivados de quinazolina
SI1131304T1 (en) N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl)-acrylamide, an irreversible inhibitor of tyrosine kinases
ECSP992885A (es) Combinaciones de estatina-inhibidor de mmp
DOP2004000812A (es) Preparacion de quinazolinas substituidas
AU2002339032A1 (en) Use of acetohydroxy acid isomeroreductase inhibitors for treating fungal diseases affecting crops